Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Neoplasms 1Neoplasm Metastasis 1Fibrosis 1Colon Cancer Liver Metastasis 1Carcinoma, Pancreatic Ductal 1Ascites 1Abdominal Neoplasms 1Abdominal Injuries 1

Interventions

Blood Specimen Collection 7Pentoxifylline 4Liver Transplantation 4Magnetic Resonance Spectroscopy 3Tocopherols 2Low-Level Light Therapy 2High-Energy Shock Waves 2tremelimumab 1sonidegib 1maltodextrin 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1apixaban 1alpha-Tocopherol 1Vitamin E 1Vitamin D 1User-Centered Design 1Tenofovir 1Surveys and Questionnaires 1Sunitinib 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Sorafenib 1Sonazoid 1Sodium Chloride 1Sampling Studies 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fibrosis × contrast agent BR1 × Clear all
NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Unknown
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡